A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins-Reference-Cited by-同舟云学术

A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins

Published:2017-01-17 Issue:4 Volume:65 Page:1104-1116
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Tsukuda Senko¹²,Watashi Koichi¹³⁴,Hojima Taichi⁵,Isogawa Masanori⁶,Iwamoto Masashi¹³,Omagari Katsumi⁶,Suzuki Ryosuke¹,Aizaki Hideki¹,Kojima Soichi²,Sugiyama Masaya⁷,Saito Akiko⁵,Tanaka Yasuhito⁶,Mizokami Masashi⁷,Sureau Camille⁸,Wakita Takaji¹

Affiliation:

1. Department of Virology II; National Institute of Infectious Diseases; Tokyo Japan

2. Micro-Signaling Regulation Technology Unit; RIKEN CLST; Wako Japan

3. Department of Applied Biological Science; Tokyo University of Science; Noda Japan

4. CREST; Japan Science and Technology Agency (JST); Saitama Japan

5. Department of Advanced Science and Engineering, Graduate School of Engineering; Osaka Electro-Communication University; Neyagawa Japan

6. Department of Virology and Liver Unit; Nagoya City University Graduate School of Medicinal Sciences; Nagoya Japan

7. Research Center for Hepatitis and Immunology; National Center for Global Health and Medicine; Ichikawa Japan

8. Laboratoire de Virologie Moléculaire; Institut National de la Transfusion Sanguine; Paris France

Funder

the Ministry of Health, Labor, and Welfare, Japan

the Ministry of Education, Cultures, Sports, Science, and Technology, Japan

the Japan Society for the Promotion of Science KAKENHI

JST CREST program

the Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED

Publisher

Wiley

Subject

Hepatology

Reference44 articles.

1. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity;Ott;Vaccine,2012

2. Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection;Liu;World J Gastroenterol,2014

3. Chronic hepatitis B;Lok;N Engl J Med,2002

4. Bridging basic science and clinical research: the EASL Monothematic Conference on Translational Research in Viral Hepatitis;Boettler;J Hepatol,2014

5. Towards an HBV cure: state-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure;Zeisel;Gut,2015

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The application and functional mechanism of Chinese herbal medicines in the treatment of chronic hepatitis B;Future Virology;2024-09-05

2. Targeting NTCP for liver disease treatment: A promising strategy;Journal of Pharmaceutical Analysis;2024-09

3. Bile acid–microbiota crosstalk in hepatitis B virus infection;Journal of Gastroenterology and Hepatology;2024-05-09

4. Antiviral Therapy of Chronic Hepatitis B Virus between Present and Future;Journal of Clinical Medicine;2024-04-02

5. Advances in Nanocarriers for Delivering Therapeutic Agents Against Hepatitis B Virus;Advanced NanoBiomed Research;2024-03-25